These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9644121)

  • 1. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.
    Goldberg D; Cameron S; McMenamin J
    Commun Dis Public Health; 1998 Jun; 1(2):95-7. PubMed ID: 9644121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?
    Taylor A; Goldberg D; Hutchinson S; Cameron S; Gore SM; McMenamin J; Green S; Pithie A; Fox R
    J Infect; 2000 Mar; 40(2):176-83. PubMed ID: 10841096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in HCV prevalence among injecting drug users in Glasgow and Edinburgh during the era of needle/syringe exchange.
    Goldberg D; Burns S; Taylor A; Cameron S; Hargreaves D; Hutchinson S
    Scand J Infect Dis; 2001; 33(6):457-61. PubMed ID: 11450866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
    Falster K; Kaldor JM; Maher L;
    J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.
    Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; Rhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D
    J Viral Hepat; 2005 Nov; 12(6):655-62. PubMed ID: 16255768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between alcohol use and hepatitis C status among injecting drug users in Glasgow.
    O'Leary MC; Hutchinson SJ; Allen E; Palmateer N; Cameron S; Taylor A; Goldberg DJ
    Drug Alcohol Depend; 2012 Jun; 123(1-3):180-9. PubMed ID: 22137645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
    Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
    J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.
    Roy KM; Hutchinson SJ; Wadd S; Taylor A; Cameron SO; Burns S; Molyneaux P; McIntyre PG; Goldberg DJ
    Epidemiol Infect; 2007 Apr; 135(3):433-42. PubMed ID: 16893486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibodies to hepatitis C virus, HIV and human T-cell leukaemia/lymphoma viruses in injecting drug users in Tayside, Scotland, 1993-7.
    McIntyre PG; Hill DA; Appleyard K; Taylor A; Hutchinson S; Goldberg DJ
    Epidemiol Infect; 2001 Feb; 126(1):97-101. PubMed ID: 11293687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
    Miller M; Mella I; Moi H; Eskild A
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
    van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
    Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method to detect the incidence of hepatitis C infection among injecting drug users in Glasgow 1993-98.
    Roy KM; Goldberg D; Taylor A; Hutchinson S; MacDonald L; Wilson KS; Cameron SO
    J Infect; 2001 Oct; 43(3):200-5. PubMed ID: 11798260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hepatitis C infection among injection drug users in Mizoram, India.
    Chelleng PK; Borkakoty BJ; Chetia M; Das HK; Mahanta J
    Indian J Med Res; 2008 Nov; 128(5):640-6. PubMed ID: 19179686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.
    Hahn JA; Page-Shafer K; Lum PJ; Ochoa K; Moss AR
    Hepatology; 2001 Jul; 34(1):180-7. PubMed ID: 11431749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.
    Boodram B; Golub ET; Ouellet LJ
    Drug Alcohol Depend; 2010 Sep; 111(1-2):136-45. PubMed ID: 20472373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.